Yellow fever treatment market to exceed US $ 607.6 million


SEATTLE, November 22, 2021 (GLOBE NEWSWIRE) – According to Coherent Market Insights, the global market yellow fever treatment market is estimated at $ 470.5 million in 2021 and should present a TCCA of 3.7% during the forecast period (2021-2028).

Key trends and analysis of the global yellow fever treatment market:

Major market trends include the initiation of research projects, which are expected to drive the growth of the global yellow fever treatment market during the forecast period. For example, in August 2021, USF researchers launched a smartphone app that was supposed to automatically identify species that carry diseases such as Aedes aegypti, a known transmitter of Zika, dengue, and yellow fever. With the help of this application, a robust image database can be built that identifies mosquitoes and monitors their habitat using an integrative approach. Images of mosquitoes, along with details of their habitat, are essential in training the AI ​​algorithm, which categorizes the anatomical components of the insect and matches them with known characteristics of Aedes aegypti.

Request a copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/4774
Key points of the market:

The global yellow fever treatment market is expected to post a CAGR of 3.7% during the forecast period. Growing funds and support from various organizations for research and development of new yellow fever drugs are expected to boost the yellow fever treatment market during the forecast period. For example, in September 2018, BioCryst Pharmaceuticals, Inc. announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, had granted BioCryst an additional US $ 3.5 million to support clinical trials of galidesivir. , an analogue of adenosine, a broad-spectrum antiviral drug in patients with yellow fever.

Based on the applications, the hospital segment is expected to represent a significant share of the global yellow fever vaccine market by 2031 due to the easy access for outpatient services (OPD) patients to purchase drugs.

Competitive landscape:

The major players operating in the global yellow fever treatment market are Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar and FSUE Chumakov

Buy this research report now @ https://www.coherentmarketinsights.com/insight/buy-now/4774

Market segmentation :

  • Global Yellow Fever Treatment Market, By Transmission Type:
    • Sylvatic yellow fever
    • Intermediate yellow fever
    • Urban yellow fever
  • Global Yellow Fever Treatment Market, By Treatment Type:
    • Vaccines
    • Medications
    • Others
  • Global Yellow Fever Treatment Market, By Application:
    • Hospitals
    • Clinics
    • Community health centers
    • Others
  • Global Yellow Fever Treatment Market, By Region:
    • North America
    • Latin America
      • By country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By country
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of europe
    • Asia Pacific
      • By country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country
        • CCG
        • Israel
        • Rest of the Middle East
    • Africa
      • By country / region
        • South Africa
        • central Africa
        • North Africa

Related Market Intelligence Reports:

Antimalarial Drugs Market, by drug class (aminoquinolines, quinoline-methanol (4-quinolinemethanols), cinchona alkaloids, biguanides, sulfonamides and sulfones and others), by route of administration (oral and injectable), by distribution channel (hospital pharmacies, pharmacies Retail & Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook and Opportunity Analysis, 2019-2027

Hydroxychloroquine Market, by disease indication (malaria, coronavirus disease, lupus erythematosus and rheumatoid arthritis), by distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) and by region (North America, Latin America, Europe, Asia- Pacific, Middle East & Africa) Size, Share, Outlook and Opportunity Analysis, 2019 – 2027

About Us:

Consistent market information is a global market intelligence and consulting organization that aims to help our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is located in India, we have a sales office in the world financial capital in the United States, and sales consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 57 countries around the world.

Follow us: LinkedIn | Twitter



Comments are closed.